T. Ishida et al., ENHANCING EFFECT OF CHOLESTEROL ON THE ELIMINATION OF LIPOSOMES FROM CIRCULATION IS MEDIATED BY COMPLEMENT ACTIVATION, International journal of pharmaceutics, 156(1), 1997, pp. 27-37
The effects of cholesterol (Chol) content on the biodistribution of li
posomes as well as the interaction of liposomes with plasma proteins,
primarily complement (C) components, were examined in this study. The
elimination of liposomes from blood circulation was enhanced by increa
sing the Chol content in liposomes. Furthermore, included Chol augment
ed the rate of liposome degradation as measured by the urinary excreti
on of H-3-inulin encapsulated in liposomes. We have also examined the
effect of liposomal Chol on organ clearance (CL) and renal CL (CLrel).
The values of organ CL and CLrel reflect the affinity of liposomes fo
r the organ and the degree of liposome degradation in the blood, respe
ctively, Hepatic CL and CLrel, but not splenic CL, increased with the
rise of Chol content in liposomes. The amount of liposome degradation
in vitro, which reflects the extent of C activation, was correlated wi
th degradation observed in vivo (CLrel). However, the amount of plasma
proteins bound to the liposomes was inversely proportional to the ext
ent of in vitro liposome degradation. We have investigated the role of
C activating factor (CAF) (Funato et al., 1994, Plasma factor trigger
ing alternative complement pathway activation by liposomes, Pharm. Res
., 11, 372-376) on Chol-dependent-C activation. Our results showed tha
t binding of CAF to the liposomes is directly proportional to the amou
nt of Chol present in the liposome. Thus, C activation by Chol in lipo
somes may proceed via a mechanism involving CAF. Taken together, these
results suggest that increasing the Chol content of liposomes enhance
s the binding of CAF to the liposomes, which in turn, mediates Chol de
pendent-C activation, resulting in the augmentation of both degradatio
n in blood and hepatic uptake of the liposomes. (C) 1997 Elsevier Scie
nce B.V.